Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPLP.L Regulatory News (PLP)

  • There is currently no data for PLP

Director/PDMR Shareholding

24 May 2018 16:27

RNS Number : 2471P
Polypipe Group PLC
24 May 2018
Β 

Polypipe Group plc (the "Company")

Notification of transaction by Person Discharging Managerial Responsibilities

The Company announces that today, 24 May 2018, Martin Payne, Chief Executive Officer and a Person Discharging Managerial Responsibilities, exercised a nil-cost option over 11,035 ordinary shares of Β£0.001 each in the capital of the Company ('Shares'), in accordance with the Deferred Share Award that was granted to him on 31 May 2016, full details of which were included in a regulatory announcement released on 31 May 2016 and in the Company's 2016 Annual Report and Accounts. The Company's Employee Benefit Trust has today transferred 5,849 Shares to Mr. Payne which represents the net number of Shares due to him after the addition of dividend shares and the appropriate tax and national insurance liabilities were taken into account. Mr. Payne now holds an interest in a total of 115,575 Shares in the Company.

The notification below, which has been made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Β 

Martin Payne

Β 

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Β 

Chief Executive Officer/Director and PDMR

b)

Β 

Initial notification /Amendment

Β 

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Β 

Polypipe Group plc

b)

Β 

LEI

Β 

Β 

2138005IF1N2RKJ6KO18

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Β 

Ordinary Shares ("Shares") of Β£0.001 each in the capital of Polypipe Group plc

Β 

Β 

GB00BKRC5K31

Β 

b)

Β 

Nature of the transaction

Β 

Β 

Acquisition of Shares for no consideration pursuant to the exercise of nil-cost options granted as a Deferred Share Award on 31 May 2016.

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

Nil

Β 

10,449 - Number of Shares vesting and over which option was exercised.

Β 

586 - Number of Shares awarded at vesting in lieu of dividends paid during the vesting period

Β 

5,849 - Number of Shares acquired after reduction for appropriate tax and national insurance liabilities.

Β 

Β 

Β 

d)

Β 

Aggregated information

Β 

Β 

- Aggregated volume

Β 

Β 

- Price

Β 

Β 

N/A

Β 

Β 

Β 

Β 

Β 

Β 

Β 

e)

Β 

Date of the transaction

Β 

Β 

24 May 2018

f)

Β 

Place of the transaction

Β 

Β 

Outside of a Trading Venue

Β 

Enquiries:

Emma Versluys, Company Secretary

+44 (0) 1709 770 000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
DSHFKQDBPBKDPPB
Date   Source Headline
7th May 20202:36 pmRNSResults of Placing
7th May 20207:01 amRNSProposed placing of new ordinary shares
7th May 20207:00 amRNSCOVID-19 Update
1st May 20204:40 pmRNSBlock listing Interim Review
7th Apr 202012:10 pmRNSNotice of AGM
25th Mar 20202:40 pmRNSCOVID 19 update
17th Mar 20207:00 amRNSFinal Results
16th Mar 202011:41 amRNSHolding(s) in Company
4th Feb 202010:26 amRNSDirector Declaration
31st Dec 201911:00 amRNSTotal Voting Rights
6th Dec 20191:17 pmRNSDirector/PDMR Shareholding
25th Nov 20193:24 pmRNSDirector/PDMR Shareholding
19th Nov 20197:00 amRNSTrading Update
7th Nov 20199:30 amRNSHolding(s) in Company
31st Oct 201910:09 amRNSBlock Listing Application
22nd Oct 20192:51 pmRNSDirector Declaration
1st Oct 20197:00 amRNSAcquisition of Alderburgh group of companies
24th Sep 20194:22 pmRNSHolding(s) in Company
18th Sep 20194:18 pmRNSDirector/PDMR Shareholding
16th Sep 20194:12 pmRNSDirectorate Change
2nd Sep 20192:34 pmRNSTotal Voting Rights
16th Aug 201910:01 amRNSDirector Declaration
14th Aug 20193:42 pmRNSHolding(s) in Company
13th Aug 20197:00 amRNSHalf-year Report
28th Jun 20194:00 pmRNSTotal Voting Rights
7th Jun 201911:08 amRNSDirector/PDMR Shareholding
31st May 20194:00 pmRNSTotal Voting Rights
23rd May 20191:43 pmRNSResult of AGM
23rd May 20197:00 amRNSTrading Update
30th Apr 20194:53 pmRNSTotal Voting Rights
30th Apr 20193:02 pmRNSDirector/PDMR Shareholding
30th Apr 20192:47 pmRNSDirector/PDMR Shareholding
15th Apr 20194:20 pmRNSAnnual Financial Report
2nd Apr 201912:08 pmEQSEdison Investment Research Limited: Edison issues outlook on Polypipe (PLP)
1st Apr 201911:24 amRNSHolding(s) in Company
19th Mar 20197:00 amRNSFinal Results
28th Feb 20194:15 pmRNSTotal Voting Rights
31st Jan 20194:55 pmRNSTotal Voting Rights
28th Jan 20194:27 pmRNSBoard Committee changes
30th Nov 20184:00 pmRNSTotal Voting Rights
23rd Nov 201812:59 pmRNSHolding(s) in Company
20th Nov 20187:00 amRNSTrading Update
25th Oct 20187:00 amRNSAcquisition of Manthorpe Building Products
5th Oct 20184:11 pmRNSDirector/PDMR Shareholding
17th Sep 201812:20 pmRNSHolding(s) in Company
5th Sep 20189:30 amRNSHolding(s) in Company
3rd Sep 20187:00 amRNSAcquisition of Permavoid Limited
30th Aug 20189:23 amRNSHolding(s) in Company
21st Aug 20182:49 pmRNSHolding(s) in Company
14th Aug 20187:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.